BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 4:06:00 PM | Browse: 1053 | Download: 1128
 |
Received |
|
2013-11-30 13:14 |
 |
Peer-Review Started |
|
2013-12-02 14:20 |
 |
To Make the First Decision |
|
2014-01-09 18:36 |
 |
Return for Revision |
|
2014-01-20 21:54 |
 |
Revised |
|
2014-02-17 03:13 |
 |
Second Decision |
|
2014-04-23 09:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-04-23 09:55 |
 |
Articles in Press |
|
2014-05-23 11:01 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-04-26 16:01 |
 |
Typeset the Manuscript |
|
2014-07-10 11:19 |
 |
Publish the Manuscript Online |
|
2014-07-26 13:36 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications
|
Manuscript Source |
Invited Manuscript |
All Author List |
Inaam A Nakchbandi |
Funding Agency and Grant Number |
|
Corresponding Author |
Inaam Nakchbandi, MD, FACP, Professor of Medicine, Translational Medicine, University of Heidelberg, Im Neuenheimer Feld 305, 2. OG, R210, 69120 Heidelberg, Germany. inaam.nakchbandi@immu.uni-heidelberg.de |
Key Words |
Osteoporosis; Liver disease; Fracture; Prevalence; Pathogenesis; Fibronectin; Insulin like growth factor-Ⅰ; Therapy; Vitamin D; Calcium |
Core Tip |
Up to 40% of patients with chronic liver disease may experience a fracture. The pathogenic mediators include fibronectin, insulin like growth factor-Ⅰ, and various cytokines. Decreased vitamin D and/or treatment with corticosteroids contribute to worsening bone health. Treatment should include calcium and vitamin D supplementation in all patients with chronic liver disease. Therapy with bisphosphonates should be considered, especially in patients receiving corticosteroids. |
Publish Date |
2014-07-26 13:36 |
Citation |
Nakchbandi IA. Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications. World J Gastroenterol 2014; 20(28): 9427-9438 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i28/9427.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i28.9427 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345